PF-Atlas › Clinical Trials › NCT01375049
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Aztreonam for Inhalation Solution · Phase 2
Registry ID
NCT01375049
Phase
Phase 2
Status
Completed
Drug / intervention
Aztreonam for Inhalation Solution (AZLI)
Sponsor
Gilead Sciences
Start
2011-08
About this trial
Aztreonam for Inhalation Solution is evaluated in NCT01375049, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Gilead Sciences. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01375049 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.